English
Back
Download
Log in to access Online Inquiry
Back to the Top

Wuxi Bio announced that the company noted that a procedural ...

Wuxi Bio announced that the company noted that a procedural hearing about a revised draft bill was held by the U.S. Senate.
Wuxi Bio's share price extended further decline to 21% in HK in the afternoon session.
The company reiterated that it is not a subsidiary of WUXI Apptec and does not have a human genomics business, nor does it collect human genomic data in any of its businesses.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
Translate
Report
29K Views
Comment
Sign in to post a comment
1958
Followers
14
Following
13K
Visitors
Follow
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.